NCT00099593View on ClinicalTrials.gov

Immunization Against Tumor Cells in Sezary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

September 30, 2007

Conditions
Cutaneous T-cell LymphomaSezary Syndrome
Interventions
BIOLOGICAL

Autologous Dendritic Cell Vaccine

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Department of Dermatology, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00099593 - Immunization Against Tumor Cells in Sezary Syndrome | Biotech Hunter | Biotech Hunter